18F-MFBG与68Ga-DOTATATE PET/CT在转移性副神经节瘤和嗜铬细胞瘤显像中的比较
两例转移性副神经节瘤/嗜铬细胞瘤男性患者,既往均接受过131I-MIBG治疗,本次评估时均行68Ga-DOTATATE和18F-MFBG PET/CT。68Ga-DOTATATE PET/CT在这2例患者图像中显示更多转移灶,提示其检测转移灶优于18F-MFBG PET/CT。
要点
- 两例转移性副神经节瘤/嗜铬细胞瘤患者均行68Ga-DOTATATE与18F-MFBG PET/CT。
- 68Ga-DOTATATE PET/CT图像显示更多转移灶。
- 作者认为在这2例患者中68Ga-DOTATATE PET/CT检测转移灶优于18F-MFBG PET/CT。
核心结论
- 作者认为在这2例患者中68Ga-DOTATATE PET/CT检测副神经节瘤和嗜铬细胞瘤转移灶优于18F-MFBG PET/CT。
研究设计与样本
- 两例转移性副神经节瘤/嗜铬细胞瘤男性患者在本院行PET/CT检查以了解治疗效果和疾病进展。
- 两例患者既往均接受过131I-MIBG治疗,本次评估时均行68Ga-DOTATATE和18F-MFBG PET/CT。
主要发现
- 68Ga-DOTATATE PET/CT在这2例患者图像中显示更多转移灶。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Two men with metastatic paraganglioma/pheochromocytoma underwent PET/CT examination in our hospital to understand the treatment effect and progression of the disease. Both patients had previously been treated with 131 I-MIBG, and at this evaluation, both of them underwent 68 Ga-DOTATATE and 18 F-MFBG PET/CT. The 68 Ga-DOTATATE PET/CT showed more metastases in the images of these 2 patients. This case highlighted that 68 Ga-DOTATATE PET/CT is superior to 18 F-MFBG PET/CT in detecting metastases from paraganglioma and pheochromocytoma in these 2 patients.
引用
- Deng M, Shu Q, Hu M, et al. Comparison of 18 F-MFBG and 68 Ga-DOTATATE PET/CT in the Imaging of Metastatic Paraganglioma and Pheochromocytoma. Clin Nucl Med. 2022. PMID: 35777982. doi:10.1097/RLU.0000000000004314
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。